Riboflavin, Vitamin B6, Folic Acid and Vitamin B12: study protocols
17 study groups took Riboflavin together with Vitamin B6, Folic Acid and Vitamin B12. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Riboflavin
17 study groups in 14 studies say how much Riboflavin participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg and 2.5 mg to 5 mg, 35% of 17 study groups each.
| Daily dose | Study groups |
|---|---|
| 500 mcg or less | 1 |
| 500 mcg to 1 mg | 0 |
| 1 mg to 2.5 mg | 6 |
| 2.5 mg to 5 mg | 6 |
| 5 mg to 10 mg | 1 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 0 |
| 50 mg to 100 mg | 0 |
| over 100 mg | 1 |
Dose per serving from research: Vitamin B6
17 study groups in 14 studies say how much Vitamin B6 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2.5 mg to 5 mg, 29% of 17 study groups.
| Daily dose | Study groups |
|---|---|
| 500 mcg or less | 1 |
| 500 mcg to 1 mg | 1 |
| 1 mg to 2.5 mg | 3 |
| 2.5 mg to 5 mg | 5 |
| 5 mg to 10 mg | 2 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 3 |
Dose per serving from research: Folic Acid
17 study groups in 14 studies say how much Folic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 250 mcg to 500 mcg and 500 mcg to 1 mg, 29% of 17 study groups each.
| Daily dose | Study groups |
|---|---|
| 100 mcg to 250 mcg | 4 |
| 250 mcg to 500 mcg | 5 |
| 500 mcg to 1 mg | 5 |
| 1 mg to 2.5 mg | 1 |
| 2.5 mg to 5 mg | 2 |
Dose per serving from research: Vitamin B12
17 study groups in 14 studies say how much Vitamin B12 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 5 mcg to 10 mcg, 35% of 17 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mcg or less | 1 |
| 1 mcg to 2.5 mcg | 2 |
| 2.5 mcg to 5 mcg | 3 |
| 5 mcg to 10 mcg | 6 |
| 10 mcg to 25 mcg | 0 |
| 25 mcg to 50 mcg | 2 |
| 50 mcg to 100 mcg | 0 |
| 100 mcg to 250 mcg | 0 |
| 250 mcg to 500 mcg | 3 |
Commonly used together
14 of 17 study groups took Riboflavin, Vitamin B6, Folic Acid and Vitamin B12 with something else. Shown: what 3 or more different studies gave. The 10 most common of 11.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Thiamine | 8 |
| Vitamin E | 8 |
| Vitamin C | 7 |
| Zinc | 7 |
| Iron | 5 |
| Vitamin A | 5 |
| Vitamin D | 5 |
| Copper | 4 |
| Niacin | 4 |
| Iodine | 3 |
17 study groups
| Study | ||||||
|---|---|---|---|---|---|---|
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 1.8 mg | 2.2 mg | 400 mcg | 2.6 mcg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 20 mg | 25 mg | 800 mcg | 50 mcg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women | 20 mg | 25 mg | 800 mcg | 50 mcg | — | — |
| Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial 2015 · Verum (investigational nutritional product) · Adults aged 18–65 of either sex with migraine with or without aura, and at least 3 migraine attacks per month before recruitment | 400 mg | 5 mg | 400 mcg | 6 mcg | 90 days | 63 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 10 mg | 10 mg | 1 mg | 10 mcg | 120 days | — |
| Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance 2014 · B vitamin supplementation group · Healthy preschool children selected for low urinary folate-status ranking | 1.1 mg | 730 mcg | 220 mcg | 1.2 mcg | 90 days | — |
| A 2-Year Randomized Controlled Trial With Low-Dose B-Vitamin Supplementation Shows Benefits on Bone Mineral Density in Adults With Lower B12 Status 2022 · B-vitamin treatment · Community-dwelling adults aged 50 years or older; men and women; no specific diagnosed condition, and not currently taking B-vitamin supplements at screening | 5 mg | 10 mg | 200 mcg | 10 mcg | 2 years | 103 |
| Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial 2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception | 1.8 mg | 2.6 mg | 400 mcg | 5.2 mcg | — | 870 |
| Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial 2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies | 500 mcg | 500 mcg | 150 mcg | 0.9 mcg | 36 weeks | 130 |
| A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels 2019 · Natural vitamin B complex (group N) · Healthy adults; age range and sex not specified | 3.98 mg | 3.38 mg | 690 mcg | 8.85 mcg | 6 weeks | 30 |
| A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels 2019 · Synthetic vitamin B complex (group S) · Healthy adults; age range and sex not specified | 3.98 mg | 3.38 mg | 690 mcg | 8.85 mcg | 6 weeks | 30 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 5 mg | 50 mg | 5 mg | 400 mcg | 2 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 5 mg | 50 mg | 5 mg | 400 mcg | 2 weeks | 24 |
| A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia 2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population | 1.4 mg | 1.9 mg | 400 mcg | 2.6 mcg | 12 weeks | 105 |
| Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial 2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male | 2.4 mg | 3 mg | 400 mcg | 5 mcg | 60 days | 52 |
| Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour 2002 · Folic acid, riboflavin, and vitamin B12 with vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women | 5 mg | 50 mg | 2.5 mg | 400 mcg | 12 weeks | — |
| Effects of mixed dietary supplements on total plasma homocysteine concentrations (tHcy): a randomized, double-blind, placebo-controlled trial 2012 · supplement group · hospitalized, acutely ill older patients recovering from acute illness; sex and age range not stated | 1.3 mg | 1.4 mg | 200 mcg | 1.5 mcg | 6 weeks | — |